nodes	percent_of_prediction	percent_of_DWPC	metapath
Imiquimod—CYP1A2—Thalidomide—leprosy	0.187	0.345	CbGbCtD
Imiquimod—CYP1A2—Rifampicin—leprosy	0.181	0.335	CbGbCtD
Imiquimod—CYP3A4—Rifampicin—leprosy	0.0949	0.175	CbGbCtD
Imiquimod—CYP3A4—Dapsone—leprosy	0.0783	0.145	CbGbCtD
Imiquimod—Application site dryness—Dapsone—leprosy	0.0303	0.113	CcSEcCtD
Imiquimod—Phototoxicity—Dapsone—leprosy	0.0182	0.0679	CcSEcCtD
Imiquimod—Application site burn—Dapsone—leprosy	0.0167	0.0621	CcSEcCtD
Imiquimod—Application site erythema—Dapsone—leprosy	0.0148	0.0552	CcSEcCtD
Imiquimod—Application site pruritus—Dapsone—leprosy	0.0143	0.0533	CcSEcCtD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—TLR1—leprosy	0.0116	0.0608	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—TLR1—leprosy	0.00905	0.0475	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—TLR1—leprosy	0.00879	0.0461	CbGpPWpGaD
Imiquimod—Teratogenicity—Thalidomide—leprosy	0.00852	0.0318	CcSEcCtD
Imiquimod—Application site pain—Dapsone—leprosy	0.00793	0.0296	CcSEcCtD
Imiquimod—Application site reaction—Dapsone—leprosy	0.00744	0.0278	CcSEcCtD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—CYLD—leprosy	0.00716	0.0375	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—TLR1—leprosy	0.00686	0.036	CbGpPWpGaD
Imiquimod—TLR8—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—RIPK2—leprosy	0.00677	0.0355	CbGpPWpGaD
Imiquimod—TLR8—MyD88 dependent cascade initiated on endosome—RIPK2—leprosy	0.00665	0.0349	CbGpPWpGaD
Imiquimod—TLR8—Toll Like Receptor 9 (TLR9) Cascade—RIPK2—leprosy	0.00641	0.0337	CbGpPWpGaD
Imiquimod—TLR8—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—NOD2—leprosy	0.00614	0.0322	CbGpPWpGaD
Imiquimod—TLR8—MyD88 dependent cascade initiated on endosome—NOD2—leprosy	0.00603	0.0316	CbGpPWpGaD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—TLR2—leprosy	0.00591	0.031	CbGpPWpGaD
Imiquimod—TLR8—Toll Like Receptor 9 (TLR9) Cascade—NOD2—leprosy	0.00582	0.0305	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—CYLD—leprosy	0.00542	0.0285	CbGpPWpGaD
Imiquimod—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—RIPK2—leprosy	0.00513	0.0269	CbGpPWpGaD
Imiquimod—TLR7—MyD88 dependent cascade initiated on endosome—RIPK2—leprosy	0.00504	0.0264	CbGpPWpGaD
Imiquimod—TLR7—Toll Like Receptor 9 (TLR9) Cascade—RIPK2—leprosy	0.00486	0.0255	CbGpPWpGaD
Imiquimod—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—NOD2—leprosy	0.00465	0.0244	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—TLR2—leprosy	0.00461	0.0242	CbGpPWpGaD
Imiquimod—TLR7—MyD88 dependent cascade initiated on endosome—NOD2—leprosy	0.00457	0.024	CbGpPWpGaD
Imiquimod—TLR8—Toll-Like Receptors Cascades—RIPK2—leprosy	0.00456	0.0239	CbGpPWpGaD
Imiquimod—TLR8—Toll-Like Receptors Cascades—TLR2—leprosy	0.00456	0.0239	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—TLR2—leprosy	0.00448	0.0235	CbGpPWpGaD
Imiquimod—TLR7—Toll Like Receptor 9 (TLR9) Cascade—NOD2—leprosy	0.00441	0.0231	CbGpPWpGaD
Imiquimod—TLR8—Toll-Like Receptors Cascades—NOD2—leprosy	0.00413	0.0217	CbGpPWpGaD
Imiquimod—Proteinuria—Dapsone—leprosy	0.00397	0.0148	CcSEcCtD
Imiquimod—Protein urine present—Dapsone—leprosy	0.00392	0.0146	CcSEcCtD
Imiquimod—Hernia—Thalidomide—leprosy	0.00381	0.0142	CcSEcCtD
Imiquimod—White blood cell count decreased—Thalidomide—leprosy	0.00359	0.0134	CcSEcCtD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—TLR2—leprosy	0.00349	0.0183	CbGpPWpGaD
Imiquimod—TLR7—Toll-Like Receptors Cascades—TLR2—leprosy	0.00345	0.0181	CbGpPWpGaD
Imiquimod—TLR7—Toll-Like Receptors Cascades—RIPK2—leprosy	0.00345	0.0181	CbGpPWpGaD
Imiquimod—Skin exfoliation—Dapsone—leprosy	0.00333	0.0124	CcSEcCtD
Imiquimod—TLR7—Toll-Like Receptors Cascades—NOD2—leprosy	0.00313	0.0164	CbGpPWpGaD
Imiquimod—Platelet count decreased—Thalidomide—leprosy	0.003	0.0112	CcSEcCtD
Imiquimod—Psoriasis—Thalidomide—leprosy	0.00284	0.0106	CcSEcCtD
Imiquimod—Tooth disorder—Thalidomide—leprosy	0.00275	0.0103	CcSEcCtD
Imiquimod—Skin ulcer—Thalidomide—leprosy	0.00229	0.00856	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—CYLD—leprosy	0.00229	0.012	CbGpPWpGaD
Imiquimod—Hyperaesthesia—Thalidomide—leprosy	0.00228	0.00849	CcSEcCtD
Imiquimod—Rash pustular—Thalidomide—leprosy	0.00224	0.00835	CcSEcCtD
Imiquimod—Tingling sensation—Thalidomide—leprosy	0.00222	0.00829	CcSEcCtD
Imiquimod—Influenza—Dapsone—leprosy	0.00219	0.00816	CcSEcCtD
Imiquimod—Proteinuria—Thalidomide—leprosy	0.00203	0.00758	CcSEcCtD
Imiquimod—Protein urine present—Thalidomide—leprosy	0.002	0.00748	CcSEcCtD
Imiquimod—Photosensitivity reaction—Dapsone—leprosy	0.002	0.00745	CcSEcCtD
Imiquimod—Viral infection—Thalidomide—leprosy	0.00198	0.00738	CcSEcCtD
Imiquimod—Herpes simplex—Thalidomide—leprosy	0.00194	0.00723	CcSEcCtD
Imiquimod—Neuropathy peripheral—Dapsone—leprosy	0.00191	0.00714	CcSEcCtD
Imiquimod—Hypercholesterolaemia—Thalidomide—leprosy	0.00189	0.00704	CcSEcCtD
Imiquimod—Bone pain—Thalidomide—leprosy	0.00186	0.00695	CcSEcCtD
Imiquimod—Sinusitis—Dapsone—leprosy	0.00183	0.00683	CcSEcCtD
Imiquimod—Pharyngitis—Dapsone—leprosy	0.00174	0.00649	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—CYLD—leprosy	0.00174	0.00911	CbGpPWpGaD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—TNF—leprosy	0.00172	0.00904	CbGpPWpGaD
Imiquimod—Skin exfoliation—Thalidomide—leprosy	0.00171	0.00636	CcSEcCtD
Imiquimod—Tinnitus—Dapsone—leprosy	0.00163	0.00609	CcSEcCtD
Imiquimod—Pulmonary oedema—Thalidomide—leprosy	0.00159	0.00593	CcSEcCtD
Imiquimod—Erythema—Dapsone—leprosy	0.00153	0.00569	CcSEcCtD
Imiquimod—Lymphadenopathy—Thalidomide—leprosy	0.00152	0.00567	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—TLR2—leprosy	0.00148	0.00775	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—RIPK2—leprosy	0.00148	0.00775	CbGpPWpGaD
Imiquimod—Eczema—Thalidomide—leprosy	0.00144	0.00538	CcSEcCtD
Imiquimod—Injury—Thalidomide—leprosy	0.00141	0.00526	CcSEcCtD
Imiquimod—Dermatitis exfoliative—Thalidomide—leprosy	0.00137	0.00512	CcSEcCtD
Imiquimod—Atrial fibrillation—Thalidomide—leprosy	0.00137	0.0051	CcSEcCtD
Imiquimod—Purpura—Thalidomide—leprosy	0.00135	0.00502	CcSEcCtD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—TNF—leprosy	0.00134	0.00706	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—NOD2—leprosy	0.00134	0.00702	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CYLD—leprosy	0.00133	0.007	CbGpPWpGaD
Imiquimod—Arthritis—Thalidomide—leprosy	0.00133	0.00498	CcSEcCtD
Imiquimod—Cough—Dapsone—leprosy	0.00133	0.00496	CcSEcCtD
Imiquimod—Cardiac failure—Thalidomide—leprosy	0.00133	0.00496	CcSEcCtD
Imiquimod—Lethargy—Thalidomide—leprosy	0.00132	0.00493	CcSEcCtD
Imiquimod—Cerebrovascular accident—Thalidomide—leprosy	0.00132	0.00493	CcSEcCtD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—TNF—leprosy	0.00131	0.00685	CbGpPWpGaD
Imiquimod—Pain in extremity—Thalidomide—leprosy	0.0013	0.00484	CcSEcCtD
Imiquimod—Migraine—Thalidomide—leprosy	0.00128	0.00476	CcSEcCtD
Imiquimod—Face oedema—Thalidomide—leprosy	0.00125	0.00467	CcSEcCtD
Imiquimod—Tachycardia—Dapsone—leprosy	0.00122	0.00453	CcSEcCtD
Imiquimod—TLR8—Immune System—PARK2—leprosy	0.00118	0.00619	CbGpPWpGaD
Imiquimod—Breast disorder—Thalidomide—leprosy	0.00117	0.00437	CcSEcCtD
Imiquimod—Insomnia—Dapsone—leprosy	0.00113	0.0042	CcSEcCtD
Imiquimod—Influenza—Thalidomide—leprosy	0.00112	0.00418	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—TLR2—leprosy	0.00112	0.00587	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—RIPK2—leprosy	0.00112	0.00587	CbGpPWpGaD
Imiquimod—Bronchitis—Thalidomide—leprosy	0.00108	0.00402	CcSEcCtD
Imiquimod—Pancytopenia—Thalidomide—leprosy	0.00106	0.00397	CcSEcCtD
Imiquimod—Upper respiratory tract infection—Thalidomide—leprosy	0.00104	0.00388	CcSEcCtD
Imiquimod—Erectile dysfunction—Thalidomide—leprosy	0.00103	0.00385	CcSEcCtD
Imiquimod—Photosensitivity reaction—Thalidomide—leprosy	0.00102	0.00381	CcSEcCtD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—TNF—leprosy	0.00102	0.00535	CbGpPWpGaD
Imiquimod—Gastrointestinal pain—Dapsone—leprosy	0.00102	0.0038	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—NOD2—leprosy	0.00101	0.00532	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CYLD—leprosy	0.00101	0.00531	CbGpPWpGaD
Imiquimod—Infestation—Thalidomide—leprosy	0.000999	0.00373	CcSEcCtD
Imiquimod—Infestation NOS—Thalidomide—leprosy	0.000999	0.00373	CcSEcCtD
Imiquimod—Depression—Thalidomide—leprosy	0.000996	0.00372	CcSEcCtD
Imiquimod—Stevens-Johnson syndrome—Thalidomide—leprosy	0.000991	0.00369	CcSEcCtD
Imiquimod—Acute coronary syndrome—Thalidomide—leprosy	0.000985	0.00367	CcSEcCtD
Imiquimod—Abdominal pain—Dapsone—leprosy	0.000984	0.00367	CcSEcCtD
Imiquimod—Body temperature increased—Dapsone—leprosy	0.000984	0.00367	CcSEcCtD
Imiquimod—Neuropathy peripheral—Thalidomide—leprosy	0.000979	0.00365	CcSEcCtD
Imiquimod—Myocardial infarction—Thalidomide—leprosy	0.000979	0.00365	CcSEcCtD
Imiquimod—Conjunctivitis—Thalidomide—leprosy	0.000971	0.00362	CcSEcCtD
Imiquimod—Sinusitis—Thalidomide—leprosy	0.000937	0.0035	CcSEcCtD
Imiquimod—Rhinitis—Thalidomide—leprosy	0.000899	0.00335	CcSEcCtD
Imiquimod—TLR7—Immune System—PARK2—leprosy	0.000894	0.00469	CbGpPWpGaD
Imiquimod—Pharyngitis—Thalidomide—leprosy	0.00089	0.00332	CcSEcCtD
Imiquimod—Urinary tract disorder—Thalidomide—leprosy	0.000886	0.0033	CcSEcCtD
Imiquimod—Urethral disorder—Thalidomide—leprosy	0.000879	0.00328	CcSEcCtD
Imiquimod—Visual impairment—Thalidomide—leprosy	0.000864	0.00322	CcSEcCtD
Imiquimod—TLR8—Immune System—TLR2—leprosy	0.00086	0.00451	CbGpPWpGaD
Imiquimod—TLR8—Immune System—RIPK2—leprosy	0.00086	0.00451	CbGpPWpGaD
Imiquimod—Erythema multiforme—Thalidomide—leprosy	0.000848	0.00316	CcSEcCtD
Imiquimod—Eye disorder—Thalidomide—leprosy	0.000838	0.00313	CcSEcCtD
Imiquimod—Tinnitus—Thalidomide—leprosy	0.000836	0.00312	CcSEcCtD
Imiquimod—Angiopathy—Thalidomide—leprosy	0.000814	0.00304	CcSEcCtD
Imiquimod—Immune system disorder—Thalidomide—leprosy	0.00081	0.00302	CcSEcCtD
Imiquimod—Mediastinal disorder—Thalidomide—leprosy	0.000808	0.00301	CcSEcCtD
Imiquimod—Chills—Thalidomide—leprosy	0.000805	0.003	CcSEcCtD
Imiquimod—Arrhythmia—Thalidomide—leprosy	0.000801	0.00299	CcSEcCtD
Imiquimod—Alopecia—Thalidomide—leprosy	0.000793	0.00296	CcSEcCtD
Imiquimod—Vomiting—Dapsone—leprosy	0.000792	0.00295	CcSEcCtD
Imiquimod—Mental disorder—Thalidomide—leprosy	0.000786	0.00293	CcSEcCtD
Imiquimod—Malnutrition—Thalidomide—leprosy	0.000781	0.00291	CcSEcCtD
Imiquimod—Headache—Dapsone—leprosy	0.00078	0.00291	CcSEcCtD
Imiquimod—TLR8—Immune System—NOD2—leprosy	0.00078	0.00409	CbGpPWpGaD
Imiquimod—Back pain—Thalidomide—leprosy	0.000755	0.00282	CcSEcCtD
Imiquimod—Nausea—Dapsone—leprosy	0.000739	0.00276	CcSEcCtD
Imiquimod—Ill-defined disorder—Thalidomide—leprosy	0.000725	0.0027	CcSEcCtD
Imiquimod—Agitation—Thalidomide—leprosy	0.000718	0.00268	CcSEcCtD
Imiquimod—Angioedema—Thalidomide—leprosy	0.000714	0.00266	CcSEcCtD
Imiquimod—Malaise—Thalidomide—leprosy	0.000704	0.00263	CcSEcCtD
Imiquimod—Syncope—Thalidomide—leprosy	0.0007	0.00261	CcSEcCtD
Imiquimod—Palpitations—Thalidomide—leprosy	0.00069	0.00257	CcSEcCtD
Imiquimod—Loss of consciousness—Thalidomide—leprosy	0.000686	0.00256	CcSEcCtD
Imiquimod—Cough—Thalidomide—leprosy	0.000681	0.00254	CcSEcCtD
Imiquimod—Convulsion—Thalidomide—leprosy	0.000677	0.00252	CcSEcCtD
Imiquimod—Hypertension—Thalidomide—leprosy	0.000674	0.00251	CcSEcCtD
Imiquimod—Arthralgia—Thalidomide—leprosy	0.000665	0.00248	CcSEcCtD
Imiquimod—Chest pain—Thalidomide—leprosy	0.000665	0.00248	CcSEcCtD
Imiquimod—Myalgia—Thalidomide—leprosy	0.000665	0.00248	CcSEcCtD
Imiquimod—Anxiety—Thalidomide—leprosy	0.000663	0.00247	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.00066	0.00246	CcSEcCtD
Imiquimod—TLR8—Immune System—CD40LG—leprosy	0.000659	0.00346	CbGpPWpGaD
Imiquimod—Discomfort—Thalidomide—leprosy	0.000657	0.00245	CcSEcCtD
Imiquimod—TLR7—Immune System—RIPK2—leprosy	0.000652	0.00342	CbGpPWpGaD
Imiquimod—TLR7—Immune System—TLR2—leprosy	0.000652	0.00342	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CD8A—leprosy	0.000652	0.00342	CbGpPWpGaD
Imiquimod—Dry mouth—Thalidomide—leprosy	0.00065	0.00242	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—CD4—leprosy	0.000643	0.00337	CbGpPWpGaD
Imiquimod—Oedema—Thalidomide—leprosy	0.000637	0.00238	CcSEcCtD
Imiquimod—Infection—Thalidomide—leprosy	0.000633	0.00236	CcSEcCtD
Imiquimod—Shock—Thalidomide—leprosy	0.000627	0.00234	CcSEcCtD
Imiquimod—Nervous system disorder—Thalidomide—leprosy	0.000625	0.00233	CcSEcCtD
Imiquimod—Tachycardia—Thalidomide—leprosy	0.000622	0.00232	CcSEcCtD
Imiquimod—Skin disorder—Thalidomide—leprosy	0.000619	0.00231	CcSEcCtD
Imiquimod—Hyperhidrosis—Thalidomide—leprosy	0.000616	0.0023	CcSEcCtD
Imiquimod—Anorexia—Thalidomide—leprosy	0.000607	0.00227	CcSEcCtD
Imiquimod—TLR7—Immune System—NOD2—leprosy	0.000591	0.0031	CbGpPWpGaD
Imiquimod—Musculoskeletal discomfort—Thalidomide—leprosy	0.000581	0.00217	CcSEcCtD
Imiquimod—Insomnia—Thalidomide—leprosy	0.000576	0.00215	CcSEcCtD
Imiquimod—Paraesthesia—Thalidomide—leprosy	0.000572	0.00213	CcSEcCtD
Imiquimod—Dyspnoea—Thalidomide—leprosy	0.000568	0.00212	CcSEcCtD
Imiquimod—Somnolence—Thalidomide—leprosy	0.000567	0.00211	CcSEcCtD
Imiquimod—Dyspepsia—Thalidomide—leprosy	0.000561	0.00209	CcSEcCtD
Imiquimod—Decreased appetite—Thalidomide—leprosy	0.000554	0.00207	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Thalidomide—leprosy	0.00055	0.00205	CcSEcCtD
Imiquimod—Fatigue—Thalidomide—leprosy	0.000549	0.00205	CcSEcCtD
Imiquimod—Pain—Thalidomide—leprosy	0.000545	0.00203	CcSEcCtD
Imiquimod—TLR8—Immune System—HLA-DRB1—leprosy	0.000531	0.00278	CbGpPWpGaD
Imiquimod—Feeling abnormal—Thalidomide—leprosy	0.000525	0.00196	CcSEcCtD
Imiquimod—Gastrointestinal pain—Thalidomide—leprosy	0.000521	0.00194	CcSEcCtD
Imiquimod—Urticaria—Thalidomide—leprosy	0.000506	0.00189	CcSEcCtD
Imiquimod—Abdominal pain—Thalidomide—leprosy	0.000504	0.00188	CcSEcCtD
Imiquimod—Body temperature increased—Thalidomide—leprosy	0.000504	0.00188	CcSEcCtD
Imiquimod—TLR7—Immune System—CD40LG—leprosy	0.0005	0.00262	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CD8A—leprosy	0.000494	0.00259	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—CD4—leprosy	0.000487	0.00256	CbGpPWpGaD
Imiquimod—Hypersensitivity—Thalidomide—leprosy	0.00047	0.00175	CcSEcCtD
Imiquimod—Asthenia—Thalidomide—leprosy	0.000457	0.00171	CcSEcCtD
Imiquimod—Pruritus—Thalidomide—leprosy	0.000451	0.00168	CcSEcCtD
Imiquimod—Diarrhoea—Thalidomide—leprosy	0.000436	0.00163	CcSEcCtD
Imiquimod—Dizziness—Thalidomide—leprosy	0.000421	0.00157	CcSEcCtD
Imiquimod—Vomiting—Thalidomide—leprosy	0.000405	0.00151	CcSEcCtD
Imiquimod—TLR7—Immune System—HLA-DRB1—leprosy	0.000402	0.00211	CbGpPWpGaD
Imiquimod—Rash—Thalidomide—leprosy	0.000402	0.0015	CcSEcCtD
Imiquimod—Dermatitis—Thalidomide—leprosy	0.000401	0.0015	CcSEcCtD
Imiquimod—Headache—Thalidomide—leprosy	0.000399	0.00149	CcSEcCtD
Imiquimod—TLR8—Immune System—IFNG—leprosy	0.000388	0.00203	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—leprosy	0.000384	0.00202	CbGpPWpGaD
Imiquimod—Nausea—Thalidomide—leprosy	0.000379	0.00141	CcSEcCtD
Imiquimod—TLR8—Immune System—CD4—leprosy	0.000374	0.00196	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IL2—leprosy	0.000344	0.00181	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—leprosy	0.000341	0.00179	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IFNG—leprosy	0.000294	0.00154	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CD4—leprosy	0.000284	0.00149	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IL2—leprosy	0.000261	0.00137	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—leprosy	0.000249	0.0013	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—TNF—leprosy	0.000249	0.0013	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—SDHD—leprosy	9.26e-05	0.000486	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—SDHD—leprosy	7.15e-05	0.000375	CbGpPWpGaD
